Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies

被引:292
作者
Li, L. [1 ]
Liu, D-W. [2 ]
Yan, H-Y. [3 ]
Wang, Z-Y. [4 ]
Zhao, S-H. [1 ]
Wang, B. [1 ]
机构
[1] Qingdao Univ, Dept Endocrinol, Affiliated Hosp, Qingdao 266003, Peoples R China
[2] Third Mil Med Univ, Dept Urinary Surg, Southwest Hosp, Chongqing, Peoples R China
[3] 210 Hosp PLA, Dept Gastroenterol, Dalian, Peoples R China
[4] Zhucheng Peoples Hosp, Surg Ctr, Zhucheng, Peoples R China
关键词
nonalcoholic fatty liver disease; obesity; risk factor; METABOLIC SYNDROME; ALCOHOL-CONSUMPTION; CHINESE POPULATION; BODY-WEIGHT; LIFE-STYLE; PREVALENCE; PREDICTORS; SPLEEN; ONSET; STEATOHEPATITIS;
D O I
10.1111/obr.12407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe association between obesity and nonalcoholic fatty liver disease (NAFLD) has not been fully quantified, and the magnitude of NAFLD risk associated with obesity is still unclear. A meta-analysis of cohort studies was performed to elucidate the NAFLD risk associated with obesity. MethodsPubmed, Web of Science and Embase were searched for cohort studies assessing NAFLD risk associated with obesity or increased body mass index (BMI). Relative risks (RRs) with 95% confidence intervals (95%CIs) were pooled using random-effects model of meta-analysis. ResultsTwenty-one cohort studies including 13 prospective studies and 8 retrospective studies were finally included. There were a total of 381,655 participants in the meta-analysis. Compared with normal weight, obesity independently led to a 3.5-fold increased risk of developing NAFLD (RR=3.53, 95%CI 2.48 to 5.03, P<0.001). Meta-analysis also suggested an obvious dose-dependent relationship between BMI and NAFLD risk (per 1-unit increment in BMI: RR=1.20, 95%CI 1.14 to 1.26, P<0.001). Subgroup analyses further identified the robustness of the association above. No obvious risk of publication bias was observed. ConclusionObese individuals have a 3.5-fold increased risk of developing NAFLD, and there is an obvious dose-dependent relationship between BMI and NAFLD risk. (c) 2016 World Obesity
引用
收藏
页码:510 / 519
页数:10
相关论文
共 50 条
  • [31] Fibroblast growth factor 21 in non-alcoholic fatty liver disease
    Tucker, Bradley
    Li, Huating
    Long, Xiaoxue
    Rye, Kerry-Anne
    Ong, Kwok Leung
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 101
  • [32] Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
    Yu, Rui
    Shi, Qiangwei
    Liu, Lei
    Chen, Lidong
    BMC GASTROENTEROLOGY, 2018, 18
  • [33] Dairy product consumption and risk of non-alcoholic fatty liver disease: A systematic review and meta-analysis of observational studies
    Yuzbashian, Emad
    Fernando, Dineli N.
    Pakseresht, Mohammadreza
    Eurich, Dean T.
    Chan, Catherine B.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (08) : 1461 - 1471
  • [34] Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis
    Rojas, Yesmi A. Ortega
    Cuellar, Claudia L. Vidal
    Barron, Karina M. Aparicio
    Arab, Juan Pablo
    Miranda, Adelina Lozano
    ANNALS OF HEPATOLOGY, 2022, 27 (06)
  • [35] Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis
    Potoupni, Victoria
    Georgiadou, Maria
    Chatzigriva, Eftychia
    Polychronidou, Georgia
    Markou, Erietta
    Zapantis Gakis, Christos
    Filimidou, Ioanna
    Karagianni, Myriam
    Anastasilakis, Dimitrios
    Evripidou, Kleo
    Ftergioti, Argyro
    Togkaridou, Marianthi
    Tsaftaridis, Nikolaos
    Apostolopoulos, Apostolos
    Polyzos, Stergios A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (11) : 3002 - 3014
  • [36] The Prevalence of Non-Alcoholic Fatty Liver Disease in Iranian Children and Adult Population: A Systematic Review and Meta-Analysis
    Hassanipour, Soheil
    Amini-Salehi, Ehsan
    Joukar, Farahnaz
    Khosousi, Mohammad-Javad
    Pourtaghi, Farideh
    Ansar, Malek Moein
    Mahdavi-Roshan, Marjan
    Heidarzad, Forough
    Rashidi-Mojdehi, Golnaz
    Abdzadeh, Elham
    Vakilpour, Azin
    Mansour-Ghanaei, Fariborz
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2023, 52 (08) : 1600 - 1612
  • [37] Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Liang, Chen
    Yu, Zhiyuan
    Bai, Li
    Hou, Wei
    Tang, Shan
    Zhang, Wei
    Chen, Xinyue
    Hu, Zhongjie
    Duan, Zhongping
    Zheng, Sujun
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [38] Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease
    Tahara, Kazuki
    Akahane, Takemi
    Namisaki, Tadashi
    Moriya, Kei
    Kawaratani, Hideto
    Kaji, Kosuke
    Takaya, Hiroaki
    Sawada, Yasuhiko
    Shimozato, Naotaka
    Sato, Shinya
    Saikawa, Soichiro
    Nakanishi, Keisuke
    Kubo, Takuya
    Fujinaga, Yukihisa
    Furukawa, Masanori
    Kitagawa, Koh
    Ozutsumi, Takahiro
    Tsuji, Yuuki
    Kaya, Daisuke
    Ogawa, Hiroyuki
    Takagi, Hirotetsu
    Ishida, Koji
    Mitoro, Akira
    Yoshiji, Hitoshi
    JGH OPEN, 2020, 4 (03): : 400 - 404
  • [39] Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood
    Cuthbertson, Daniel J.
    Brown, Emily
    Koskinen, Juha
    Magnussen, Costan G.
    Hutri-Kahonen, Nina
    Sabin, Matthew
    Tossavainen, Paeivi
    Jokinen, Eero
    Laitinen, Tomi
    Viikari, Jorma
    Raitakari, Olli T.
    Juonala, Markus
    LIVER INTERNATIONAL, 2019, 39 (06) : 1147 - 1154
  • [40] Evaluation of risk factors for non-alcoholic fatty liver disease in India: A systematic review and meta-analysis
    Kannan, Suthanthira
    Nelliyanil, Maria
    Mendagudli, Roopa
    Rajeshwari, Swetha
    Kona, Chandralekha
    Kundapur, Rashmi
    Sathyanath, Shreyaswi
    Kulkarni, Vaman
    Aggarwal, Sumit
    JOURNAL OF EDUCATION AND HEALTH PROMOTION, 2023, 12 (01)